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Introduction 
Prostate cancer represents the second widespread cancer 
and about 10% of all cancers in men.1 Although the 
incidence of prostate cancer in China, Japan, and other 
Asian countries is lower than the Western countries, it 
has grown quite rapidly recent years.2 Chemotherapy and 
radiotherapy are the mainstay to treat such a cancer.3 
5-Fluorouracil (5-FU) is one of the chemotherapy 
agents widely used as anticancer treatment, especially in 
the setting of breast and prostate cancers4; yet, nausea, 
vomiting, mucositis, stomatitis, and diarrhea remains the 
major therapeutic side-effects.5 Flavonoids are polyphenol 
compounds which are mainly found in edible and inedible 
plants with potent antioxidant and anti-radical properties.6 
Rutin is a glycoside from quercetin flavonoid found 
in plants such as green tea, and apples.7 Rutin has 
neuroprotection, anti-inflammatory, anti-carcinogenic, 
antiproliferative, and anti-oxidative stress effects through 
inhibiting the lipid peroxidation.8 Rutin stimulates 
apoptosis in many cancer cell lines such as prostate and 
HepG2,9 aside reducing Bcl-2 gene and increasing p53 
gene expression.8,10 P53, a suppressor gene, regulates the 
cell cycle and acts as a major anticancer barrier.11 Bcl-2 
proto-oncogene inhibits cell apoptosis and p53 activity.12 
Chemo-herbal anticancer combination therapy is 
currently considered as promising. Combining anti-
cancer drugs and antioxidant agents do enhance anti-
carcinogenic and anti-proliferative effects compared to 
chemotherapy alone.13,14 Rutin and apigenin, as anti-
oxidant agents, induce apoptosis in MCF-7 cancer cells 
through p53-dependent pathway, increasing anti-tumor 
activity of tamoxifen on cancer cells.15 
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Purpose: Prostate cancer is as far the most prevalent male cancer. Rutin (a glycoside from 
quercetin flavonoid) displays antioxidant activity leading to cell apoptosis. Combined effects of 
rutin with the widely used anti-cancer drug, 5-fluorouracil (5-FU), on prostate cancer cell line 
(PC3) was investigated herein.
Methods: Different concentrations of combined 5-FU and rutin were applied to PC3 cells 
compared to separate treatment for 48 hours. Cell viability, as well p53 gene expression 
respectively were assessed by MTT assay and real-time quantitative polymerase chain reaction 
(qPCR). Changes of Bcl-2 signal protein and apoptosis were determined using western blot 
and flow cytometry procedures, respectively. Clonogenic assay was used to colony counts 
assessment.
Results: 50% inhibitory concentration (IC50) of separate cell treatment with either rutin and 
5-FU respectively were 900 μM and 3Mm, while combination index (CI) of combined 5-FU 
/rutin application reached a level of synergistic effects (0.33). Combination of 5-FU/rutin 
enhanced apoptosis and p53 gene expression in PC3 cells. PC3 cell colony counts and Bcl-2 
signaling protein were decreased by 5-FU/rutin combination.
Conclusion: Synergistic effects of 5-FU/rutin combination on PC3 cells line enhanced apoptosis, 
p53 gene expression, and down-regulation of Bcl-2 protein, compared to control separate 
application. 5-FU/rutin combination does seem an interesting therapeutic pathway to be further 
investigated.
Article info
Effects of 5-fluorouracil and rutin on PC3 cells
Advanced Pharmaceutical Bulletin, 2019, Volume 9, Issue 3 463
Synergistic effects of anti-oxidant agents and 
chemotherapeutic drugs (such as combination of 
gemcitabine, 5-FU, and cisplatin) resort on induction of 
apoptosis, inhibition of cell proliferation and metastasis 
invasion.16-18 Chemo-herbal combination therapy does 
attenuate the hazards to inducing drug resistance and 
prevalence of chemotherapy side effects.19 The present 
study was designed to investigate the synergistic effects of 
rutin and 5-FU chemo-herbal combination on apoptosis, 
colony formation, p53 gene expression, and Bcl-2 signaling 
protein in PC3 prostatic cancer cells. 
Materials and Methods
Reagents 
The human PC3 prostate cancer cells were provided by 
Pasteur Institute (Tehran, Iran). Trypsin 0.25%, fetal 
bovine serum (FBS), penicillin/streptomycin (pen/
strep), and RPMI 1640 medium were prepared from 
Gibco (Rockville, MD, USA). 5-FU (50 mg/mL solution) 
was purchased from Haupt Pharma (Wolfratshausen 
GmbH Co, Germany). 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) and rutin were 
obtained from Sigma-Aldrich (St. Louis, MO, USA). 
Annexin V kit was purchased from BD Bioscience 
(California, USA). Antibodies were purchased from 
Elabscience Biotechnology Co. (Wuhan, China). 
Roti®ZOL total RNA extraction kit was prepared from 
Carl Roth GmbH (Germany). All other chemicals used 
were of analytical grade.
Cell viability/proliferation assay
Cell viability was measured by MTT assay test. PC3 cells 
were seeded in 96-well plates in RPMI 1640 medium (5000 
cells/per well) supplement with 10% FBS, 1% pen/strep 
at 37°C in 98% humidity with 5% CO2 for an overnight 
and then treated with different concentrations of 5-FU 
(0-10 μM) and rutin (0-1500 μM, solution in DMSO with 
0.1% final concentration) for 48 hours. After treatment, 
medium was removed and the cells were incubated with 
10 µL MTT solution (5 mg/mL) for 4 hours at 37ºC in a 
dark place. Then, DMSO (150 μL) was added to each well 
in order to dissolve the formazan crystals. Absorbance 
at 490 nm with a reference wavelength of 570 nm was 
calculated using a microplate reader (Stat Fax-2100, USA). 
The percentage of cell viability was assessed based on the 
absorbance of treated cells as opposed to the untreated 
control cells (viability = A (sample) / A (control) × 100).20,21
Assessment of synergistic effects of 5-FU and rutin
Synergistic effects assessment of 5-FU and rutin on PC3 
cells was based on cell viability. The combined effects of 
both 5-FU and rutin in different concentrations (0.75 μM 
5-FU and 700 μM rutin; 1 μM 5-FU and 500 μM rutin; 1.75 
μM 5-FU and 300 μM rutin; and 2.5 μM 5-FU and 100 μM 
rutin) were assessed for 48 hours. The combination index 
(CI) was used to evaluate synergistic effects of 5-FU and 
rutin and CI ˂1, =1 and ˃1 indicated synergism, additive, 
and antagonism effects respectively.22
Clonogenic assay
PC3 cells were cultured in 6-well plates at density of 2 
× 102 cells/well for an overnight in RPMI 1640 medium 
supplement with 10% FBS, 1% pen/strep. Then, PC3 
cells were treated with 5-FU (0.75 μM) or rutin (700 μM) 
separately and using their combination (0.75 μM and 700 
μM respectively) for 48 hours. The culture medium was 
removed and the plates were incubated for 14 days in 5% 
CO2 incubator at 37°C and 95% humidity in the absence of 
5-FU and rutin treatment for detecting obvious colonies. 
The culture medium was changed every 2 days. Then the 
plates were rinsed with PBS and fixed with 70% ethanol. 
The staining of colonies was done with a mixture of 0.5% 
crystal violet in 50:50 methanol:water for 30 minutes. The 
plates were rinsed with water and left for drying at room 
temperature. Then, ImageJ software (web-based open 
source software) was used to evaluate the colonies. The 
plating efficiency (PE) was measured using the following 
formula: number of colonies/number of seeded cells ×100 
and surviving fraction (SF) was determined by (number 
of colonies/number of seeded cells × PE control) ×100.23,24
Determining apoptosis 
PC3 cells (2×105 per well) were seeded into a 6-well plate 
in RPMI 1640 medium supplement with 10% FBS, 1% 
pen/strep and incubated overnight in 5% CO2 incubator 
at 37°C and 95% humidity. Then, the cells were treated 
with 5-FU (0.75 μM) and rutin (700 μM) or combination 
of 5-FU and rutin (0.75 μM and 700 μM respectively) 
for 48 hours. Subsequently, the cells were collected by 
trypsinization and washed with PBS and stained by 
Annexin V/propidium (BD Biosciences) based on the 
manufacturer’s instructions for 25 minutes at room 
temperature in a dark place.25 The stained PC3 cells 
were analyzed using a flow cytometer (FACScan; Becton 
Dickinson Immunocytometry Systems, San Jose, CA, 
USA). Experiments were performed in triplicates.
Real-time quantitative polymerase chain reaction
PC3 cells were collected after treatment with 5-FU (0.75 
μM) and rutin (700 μM) or a combination of 5-FU and rutin 
(0.75 μM and 700 μM, respectively) in 6-cm dishes after 
48 hours. Then, total mRNA was isolated using Roti®ZOL 
reagent according to the manufacturer’s protocol and the 
RNA quantity and quality were measured by 260/280 nm 
absorbance ratio using NanoDrop spectrophotometer 
(Thermo, USA). mRNA was subsequently reverse-
transcribed to cDNA using synthesis kit (Takara Bio 
Inc., Japan). cDNA was amplified by RT-qPCR using 
SYBR® Green PCR Master Mix (Takara Bio Inc, Japan) 
in the presence of specific primers for p53 (forward: 
5’-CCCATCCTCACCATCATCACAC-3’,  reverse: 
5’-GCACAAACACGCACCTCAAAG3’), and GAPDH 
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(forward: 5 ′ACACCCACTCCTCCACCCTTTG3 ′ ; 
reverse: 5′GTCCACCACCCTGTTGCTGTA-3′). The 
primers were designed with Oligo 6.0 (Molecular Biology 
Insights, Cascade, CO, USA) and confirmed by the blast 
(NCBI). The primers were obtained from (Macrogen 
Company, South Korea). The expression of p53 gene was 
done using Rotor-Gene 3000 (Corbett, Australia). RT-
qPCR program consisted of an initial denaturation stage 
of 95°C at 10 minutes. Then, a three-step program was 
developed for 40 cycles including 95°C for 10 seconds, 
62°C for 15 seconds, and 72°C for 20 seconds, respectively. 
GAPDH (glyceraldehyde-3-phosphatedehydrogenase) a 
housekeeping gene, was used as an endogenous control 
gene for the normalization of p53 expression. The relative 
quantity of the target gene was determined using the 2-ΔΔCT 
method.26 
Western blot
PC3 cells were plated into 6 dishes (6× 105 cells/dish) in 
RPMI 1640 medium supplement with 10% FBS, 1% pen/
strep and incubated overnight in 5% CO2 incubator at 
37°C and 95% humidity. The cells treated with 5-FU (0.75 
μM), rutin (700 μM), and the combination of 5-FU with 
rutin (0.75 μM and 700 μM respectively) for 48 hours. 
Then, the cells were lysed on ice using RIPA buffer (50 
mM Tris-HCl with pH 8, 150 mM NaCl, 1% v/v Triton 
100X, 0.5% w/v sodium deoxycholate, 1 mM EDTA, 0.1% 
w/v sodium azide, 50 mM NaF, 0.1% sodium dodecyl 
sulfate, 1 mM phenylmethylsulfonyl fluoride, proteas and 
phosphatase inhibitor)27 and protein concentrations were 
measured by Bradford reagent.28 The protein samples 
were mixed with an equal volume of loading buffer (0.125 
mM Tris-HCl with pH 6.8, 4% sodium dodecyl sulfate, 
20% glycine, and 10% 2-mercaptoethanol) and they were 
boiled for 5 minutes at 98°C. Denatured proteins were 
separated by 10% sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis and were transferred to polyvinylidene 
difluoride membrane. Then membranes were placed 
in a blocking solution with 5% BSA for 1 hours. The 
membranes were washed 3 times in TBS-Tween buffer 
(containing 10 mM Tris with pH 7.4, 100 mM NaCl, 
and 0.1 mM Tween-20) for 10 minutes, and they were 
incubated with primary Bcl-2 and β-actin (as an internal 
control) antibodies according to the manufacturer’s 
protocols at 4°C overnight. Then the membranes were 
washed with TBS-Tween buffer 3 times for 10 minutes 
and they were incubated with secondary antibody at room 
temperature for 2 hours. After washing the membrane 3 
times for 10 minutes in TBS-Tween buffer, bands were 
revealed by enhanced chemiluminescence (ECL; Thermo 
Fisher scientific, USA).29 
Statistical analysis
All data were presented as mean ± standard deviation 
(SD) in triplicate experiments. Statistical analysis of the 
data was done using SPSS software version 20 (SPSS Inc., 
Chicago, IL, USA) and GraphPad Prism 6 (GraphPad 
software, San Diego, CA). Kruskal-Wallis and Dunn’s 
test were used to estimate the statistical analysis between 
the treated and the control groups for real-time PCR, 
Annexin V assay, clonogenic assay, and MTT assay. The 
p value less than 0.05 was considered significant. For gene 
expression analysis, the data were normalized to GAPDH 
and results were expressed as fold change. The relative 
levels of quantitative gene expression were estimated with 
2-∆∆CT method. A melting curve analysis of each product 
was generated to ensure the purity of the amplification 
product of each reaction. Combination index (CI) was 
calculated using CompuSyn software (Combo SynInc, 
City, State, USA) and CI ˂1, =1 and ˃1 were considered as 
synergism, additive, and antagonism effects respectively. 
Results and Discussion
Effect of 5-FU and rutin on PC3 cell proliferation 
inhibition
Figure 1 A and B show cell viability of the PC3 cells treated 
with different concentrations of 5-FU and rutin for 48 
hours. Also, treated PC3 cells showed morphological 
changes in comparison with the control cells (Figure 1C). 
IC50 values of 5-FU and rutin were 3 μM and 900 μM 
respectively paralleling previous reports.30 Combination 
of 5-FU and rutin on the PC3 cells viability showed a 
synergistic effect, by displaying CI reaching 0.33 (Table 1). 
Cell viability by the current chemo-herbal combination 
was less than 30%, in agreement with previous studies.30 It 
was shown that CI less than 1 and approaching zero leads 
to less than 50% cell viability30 as observed by the current 
study. 
Natural antioxidant agents and flavonoids are easily 
accessible through the nature, and taking advantage of 
their additive cytotoxic efficiency to chemotherapeutic 
regimens is an ongoing field of investigation to 
increase expression of anti-cancer genes; yet, limiting 
chemotherapeutic side effects.31,32 Antioxidant agents 
protect cells against superoxide and hydroxyl free radicals 
through reported direct and indirect pathways.17,33 
Since 5-FU has toxic properties and clinical side effects; 
therefore, attempts were directed to combine 5-FU 
with other antioxidant agents that does reduce the 
therapeutic dose of 5-FU, while delaying development 
of drug resistance. The latter is reported to be sustained 
by multiple targeting mechanisms to chemo-herbal 
therapeutic anti-cancer combination.18,34 Rutin and 5-FU 
chemo-herbal combination investigated by the current 
study displayed superior impact on PC3 cell proliferation’s 
reduction to sole application of 5-FU or rutin as observed 
by Wang et al.30 
The ability to reduce cancer cell proliferation using 
diverse chemo-herbal combination does effect through 
activation of apoptosis, caspases 3, 8, 9, down-regulation 
related to genes deemed as Bcl-2, Bcl-XL, XIAP, and 
potentiate mediators’ expression.30,35-37 5-FU/ rutin 
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chemo-herbal combination used in the current study 
led to superior reduction in cell proliferation; though 
reducing 5-FU doses (Table 1 and Figure 1). 
Effect of 5-FU and rutin on apoptosis, gene expression of 
p53 and cellular pathway Bcl-2 in PC3 cell 
Figures 2, 3 and 4 display the observed effects of 5-FU/
rutin combination on apoptosis, p53 gene expression and 
Bcl-2 cellular signaling protein. The PC3 cells apoptosis 
percentages using separate or combination of 5-FU and 
rutin application, respectively were 15.2%, 36.73%, and 
57.8%. Comparing to the separate or control groups, 
5-FU/rutin combination significantly (P < 0.05) increased 
apoptosis (Figure 2). Rutin applied separately or in 
combination to 5-FU (Figure 3) led to enhance p53 gene 
expression in PC3 cell line by 15.2, and 24.6 fold than 
Figure 1. Anti-proliferation effect of (A) 5-FU treatment, (B) rutin treatment, and (C) morphological changes of PC3 cells after treatment with various 
concentrations of 5-FU with rutin and combination both after 48 h. a: (control), b: (5-FU, 0.75μM), c: (rutin, 700 μM), and d: 5-FU with rutin (0.75 μM 
and 700 μM respectively). Data are expressed as mean ± SD of 3 independent experiments.
Table 1. The viability percentage of PC3 cells after treated with combination of rutin and 5-FU
Combination number
Dose combination, µM
Cell viability, % CI
Rutin (IC value) 5-FU (IC value)
No. 1 100(IC10) 2.5 (IC40) 57.80±2.75 1.17
No. 2 300 (IC20) 1.75 (IC30) 60.26±2.48 1.16
No. 3 500 (IC30) 1 (IC20) 63.72±3.87 1.27
No. 4 700 (IC40) 0.75(IC10) 28.03±2.99 0.33
The results were expressed as mean ± SD of three separate experiments.
Figure 2. Effect of 5-FU and rutin on the apoptosis of PC3 cells. (A) Dot-plots from flow cytometric illustrating apoptotic status in PC3 cells. (B) Total 
percentage of apoptosis in PC3 cells treated with the indicated concentrations of 5-FU (0.75 μM) and rutin (700 μM) or a combination of 5-FU with 
rutin (0.75 μM and 700 μM respectively) for 48 h. All data were expressed as the mean ± standard deviation. aP < 0.05 vs. control cells. b P < 0.05 vs. 
5-FU treated cells.
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control cells (P < 0.05). 5-FU/rutin combination displayed 
superior level of Bcl-2 protein suppression in PC3 cells 
(Figure 4). 
Curcumin in association with 5-FU was reported to 
stimulate apoptosis, nuclear factor kappa B and p53 gene 
expression, and reduction to Bcl-2 protein in cancer 
cells,38 paralleling the results of the current study (Figures 
2, 3, and 4). As previously reported, 5-FU used separately 
or in combination with quercetin (a natural antioxidant 
agent), and melatonin in the setting of human liver and 
colon cancer cells resulted in a significant cell proliferation 
inhibition; thereby, empowering apoptosis.34,39 5-FU/rutin 
combination investigated herein displayed similar finding 
in respect to cell apoptosis enhancement (Figures 1 and 2). 
The latter effect on cell apoptosis, reduction in Bcl-2 gene 
expression and Bcl-2/Bax ratio reported10,40,41 with rutin 
corroborates the current results (Figures 3 and 4).
The anti-proliferative mechanism of antioxidant 
agents such as rutin was described occurring through 
prolongation of initial and final apoptosis process by 
over-expression of Gstp1, Cyp1A1, p38 in special.7,42 Anti-
cancers chemotherapeutic properties are thought to be 
empowered using combination with antioxidant agents, 
Figure 3. Expression of p53 in PC3 cells at 0.75μM of 5-FU and 700 
μM rutin or a combination of 5-FU with rutin (0.75 μM and 700 
μM respectively) for 48 h. The expression of p53 was normalized to 
GAPDH. Columns and bars demonstrated mean ± SD of three separate 
experiments. aP < 0.05 vs. control cells. bP < 0.05 vs. 5-FU treated cells.
Figure 4. (A) Quantification of Western blot bands by densitometry. (B) Western blot analysis performed on PC3 cells were treated with 5-FU (0.75 μM), rutin (700 
μM), and combined doses of 5-FU (0.75μM) and rutin (700 μM) for 48 h. a P < 0.05 vs. control cells. b P < 0.05 vs. 5-FU treated cells.
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in particular by leading towards apoptosis induction.42,43 
Increasing the Bax and caspase 3, 8, 9 expressions, 
designed as positive apoptosis regulator, in one hand, and 
reduction in Bcl-2 expression on human colon cancer 
cells in another, were found using combination of rutin 
and hyperoside.44 Rutin alone or in combination to 5-FU/
oxaliplatin regimen in face of Caco-2 human colon cancer 
cells, caused phospho-Bad, cleaved caspase 3, and cleaved 
PARP level up-taking .31 Antioxidant agents such as rutin 
cause the release of cytochrome C from mitochondria 
into the cytoplasm and activate apoptosis via p53.45 The 
aptitude of antioxidant agents to inhibit cell proliferation 
and induce caspase-dependent apoptosis is sustained 
by activating p53 tumor suppresser protein, and down-
regulating MDM2.46
5-FU has anticancer activities by increasing apoptosis 
through induction of p53-dependent mitochondrial 
pathway, releasing cytochrome C from mitochondria 
into cytoplasm, and activating caspase-9 and caspase3. 
5-FU reduces expression of anti-apoptotic protein Bcl-
2.47 An alternative mitochondrial mechanism leading 
to potentiate cell apoptosis through expression of p53 
(a tumor suppressor gene) that binds to Bcl-2 and Bcl-
XL proteins, therefore, activating Bak and Bax apoptotic 
proteins is advocated.48 Therefore, in the present study 
induction of PC3 cell apoptosis may be, at least partly, 
due to elevation of p53 gene expression plus reduction 
of Bcl-2 protein. In addition, our results showed that 
administration of rutin with 5-FU not only increases the 
anti-tumor effects of 5-FU but also it reduces 5-FU dose. 
Clonogenic assay 
Figure 5 displays the number of colonies in treated PC3 
cell in the presence and absence of 5-FU, rutin, and their 
combination after 14 days. The dishes consisting of 88, 50, 
33, and 9 colonies for control, 5-FU, rutin and combination 
of 5-FU with rutin respectively (Figure 5B). The number 
of colonies in the setting of 5-FU/rutin combination 
were remarkably less than that of control or separate 
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application of 5-FU. Surviving fraction (SF) of colonies 
for 5-FU, rutin, and 5-FU/rutin combination were 56.8%, 
37.5%, and 10.2% respectively. Figure 5A shows PE in 
control and treated experimental groups. PE showed a 
significant decrease (P < 0.05) in 5-FU/rutin combination 
in comparison with the control group or separately 
application of 5-FU. The current results pointed out that 
the number of colonies and Bcl-2 protein diminished in the 
case of 5-FU/rutin combination, compared to untreated 
control cells or by 5-FU application lonely (Figures 5 and 
4). Therefore, the reduction in the number of colonies and 
Bcl-2 signaling protein in 5-FU/rutin combination does 
reflect the expected synergetic impact on PC3 cancer cells 
apoptosis induction.
As the main limitation, effects of 5-FU/rutin 
combination on cell cycle factors such as G2, G1 and NF-
Kappa, p38, caspases pathway, and the expression of pro-
apoptotic genes (Bax and Bak) were not assessed by the 
current study. Thus, we suggest that future studies focus 
on the combined effects of rutin and 5-FU on the above 
factors.
Conclusion 
The current study reported 5-FU/rutin combination as 
being prone to significantly inhibit PC3 cell proliferation, 
inducing apoptosis via down-regulation of Bcl-2, and 
activating the tumor suppressor protein p53 in PC3 human 
prostatic cancer cells. Nevertheless, further investigations 
are needed to assess 5-FU/rutin combination on expression 
of others anti or pro-apoptotic pathways. 
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